Raymond James Maintains Outperform on HCA Healthcare, Raises Price Target to $300
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst John Ransom has maintained an Outperform rating on HCA Healthcare (NYSE:HCA) and increased the price target from $280 to $300.
January 24, 2024 | 8:23 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Raymond James has reaffirmed HCA Healthcare's Outperform rating and raised the price target from $280 to $300, indicating a positive outlook on the stock.
The increase in price target by a reputable analyst like John Ransom from Raymond James typically signals a strong conviction in the company's future performance and can positively influence investor sentiment, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100